You’re invited to attend a Charter Lecture hosted by Royal Society of Biology with The Biomedical Students Society.
For more info and to see if there is still space on the free transport, contact the society via their email - email@example.com
Topic: Liquid Biopsy
The liquid biopsy holds potential as a tool for detecting and monitoring cancer, for predicting relapse and response. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) are most widely investigated but other blood based markers are also under active investigation. Recent research by Jacqui's lab and others has shown that profiling of somatic copy number alterations and mutations in circulating cell-free DNA (cfDNA) can detect minimal residual disease and predict who will relapse after cancer treatment.
In this annual charter lecture Jacqui will introduce the field of liquid biopsies and discuss some of the recent research from her group focussing on breast and lung cancers.
About the speaker
Jacqui Shaw is professor of translational cancer genetics and director of the Leicester Precision Medicine Institute at the University of Leicester. She leads a research team of high national and international standing sustained through > £3M current grant funding.
Her research is focussed on analysis of circulating tumour DNA (ctDNA) for detection and monitoring of breast cancer. She has published a number of first in field papers and her research was recommended by Faculty 1000 (F1000) as “an example of bench to bedside science that might be useful in the risk assessment and the monitoring of cancer”.
Jacqui holds programme grant funding from Cancer Research UK in breast cancer and is the cfDNA lead for the national TRACERx trial in NSCLC. She also led the cfDNA advisory group for Genomics England and sits on a number of national committees and editorial boards.